REGN vs TITN · P/E 14, rev $4.29B vs rev $1.02B
Regeneron Pharmaceuticals Inc (REGN) versus Titan Machinery Inc (TITN) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Titan Machinery Inc (TITN) is a industrial distribution company listed on NASDAQ.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TITN revenue for 2026-07-31 was $1.02B. Net income was -$21.8M. Revenue was up 95.0% from 2026-04-30 to 2026-07-31. TITN currently screens at market cap $452.3M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TITN currently screens at market cap $452.3M.
Not investment advice. Open the REGN and TITN stock pages for the full models.
Not investment advice.